HPV vaccination in women aged 24-45 years

Diane Solomon; Phil Castle; Allan Hildesheim; Hormuzd A. Katki; Mark Schiffman; Sholom Wacholder

doi:10.1016/S0140-6736(09)61782-7

HPV vaccination in women aged 24-45 years

Diane Solomon, Phil Castle, Allan Hildesheim, Hormuzd A. Katki, Mark Schiffman, Sholom Wacholder

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1239
Number of pages	1
Journal	The Lancet
Volume	374
Issue number	9697
DOIs	https://doi.org/10.1016/S0140-6736(09)61782-7
State	Published - 2009
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0140-6736(09)61782-7

Cite this

@article{5d132c309abe4d4784921f204f622445,

title = "HPV vaccination in women aged 24-45 years",

author = "Diane Solomon and Phil Castle and Allan Hildesheim and Katki, {Hormuzd A.} and Mark Schiffman and Sholom Wacholder",

note = "Funding Information: DS, AH, MS, and SW are investigators for the Costa Rican Vaccine Trial. The trial was sponsored by the US National Cancer Institute, but GlaxoSmithKline provided vaccine and support for aspects of the trial associated with the regulatory submission needs of the US Food and Drug Administration. ",

year = "2009",

doi = "10.1016/S0140-6736(09)61782-7",

language = "English (US)",

volume = "374",

pages = "1239",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "9697",

}

TY - JOUR

T1 - HPV vaccination in women aged 24-45 years

AU - Solomon, Diane

AU - Castle, Phil

AU - Hildesheim, Allan

AU - Katki, Hormuzd A.

AU - Schiffman, Mark

AU - Wacholder, Sholom

N1 - Funding Information: DS, AH, MS, and SW are investigators for the Costa Rican Vaccine Trial. The trial was sponsored by the US National Cancer Institute, but GlaxoSmithKline provided vaccine and support for aspects of the trial associated with the regulatory submission needs of the US Food and Drug Administration.

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=70349974985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349974985&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(09)61782-7

DO - 10.1016/S0140-6736(09)61782-7

M3 - Letter

C2 - 19819386

AN - SCOPUS:70349974985

SN - 0140-6736

VL - 374

SP - 1239

JO - The Lancet

JF - The Lancet

IS - 9697

ER -

HPV vaccination in women aged 24-45 years

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this